![Jose Manuel Valdivielso Revilla](/media/upload/cache/129697_a115x115.jpg)
Jose Manuel Valdivielso Revilla
Grado: Doctor/a
973 702 952
valdivielso(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/B-5673-2009
Publicaciones
-
Borràs Sans M; Pérez-Fontán M; Martinez-Alonso M; Bajo A; Betriu À; Valdivielso JM; Fernández E
The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
PLOS ONE 12 -. .
-
Abajo M; Betriu À; Arroyo D; Gracia M; Del Pino MD; Martínez I; Valdivielso JM; Fernández E
Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study
NEPHROLOGY DIALYSIS TRANSPLANTATION 32 1882-1891. .
-
Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E
Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound
PLOS ONE 12 -. .
-
Khan AUH; Allende-Vega, N; Gitenay, D; Gerbal-Chaloin, S; Gondeau, C; Vo, DN; Belkahla, S; Orecchioni, S; Talarico, G; Bertolini, F; Bozic, M; Valdivielso, JM; Bejjani, F; Jariel, I; Lopez-Mejia, IC; Fajas, L; Lecellier, CH; Hernandez, J; Daujat, M; Villalba, M
The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway
SCIENTIFIC REPORTS 7 10654-10654. .
-
Bermudez-Lopez, M; Arroyo, D; Betriu À; Masana, L; Fernandez, E; Valdivielso, JM
New perspectives on CKD-induced dyslipidemia
Expert Opinion On Therapeutic Targets 21 967-976. .
-
Fernandez-Laso, V; Mendez-Barbero, N; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
Atherosclerosis 260 130-137. .
-
Gracia, M; Betriu, A; Martinez, M; Arroyo, D; Abajo, M; Fernandez, E; Valdivielso, JM
KLOTHO GENE POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION OF ATHEROMATOSIS IN PATIENTS WITH CKD. RESULTS OF TWO YEARS FOLLOW-UP OF THE NEFRONA COHORT
NEPHROLOGY DIALYSIS TRANSPLANTATION 32 -. .
-
Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. .
-
Torremade, N; Bozic, M; Goltzman, D; Fernandez, E; Valdivielso, JM
Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase
PLOS ONE 12 -. .
-
Arcidiacono, MV; Martinez-Alonso, M; Belart, M; Vilar, A; Martin, M; Craver, L; Betriu À; Mauricio, D; Valdivielso, JM; Fernandez, E; Borràs M
High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease
Mediators of Inflammation 2017 3795142-3795142. .
-
Bozic, M; Valdivielso, JM
Functional Distribution and Regulation of the NMDAR in the Kidney, Heart and Parathyroid Gland
Receptors Series 30 51-68. .
-
Fontan, MP; Sans, MB; Rubio, MAB; Rodriguez-Carmona, A; Betriu, A; Valdivielso, JM; Fernandez, E; NEFRONA Study Investigators
Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study
Nephron 136 111-120. .
Proyectos
- Estancias de personal docente y/o investigador senior en centros extranjeros 2022
- El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
- Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
- SPAIN CKD CAUSE (SPACKDC)
- INVESTIGO 2022: Grup de recerca translacional vascular i renal
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
- Acciones de Dinamización "Europa Investigación 2020"
- Contratos Sara Borrell
- Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
- Ajuts destinats a contractar personal investigador novell (FI)
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.